TY - JOUR
T1 - Physical Methods for Intracellular Delivery
T2 - Practical Aspects from Laboratory Use to Industrial-Scale Processing
AU - Meacham, J. Mark
AU - Durvasula, Kiranmai
AU - Degertekin, F. Levent
AU - Fedorov, Andrei G.
N1 - Funding Information:
The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported in part by the National Institutes of Health National Institute of General Medical Sciences (NIH-NIGMS; grant 8R44GM103448-03).
PY - 2014/2
Y1 - 2014/2
N2 - Effective intracellular delivery is a significant impediment to research and therapeutic applications at all processing scales. Physical delivery methods have long demonstrated the ability to deliver cargo molecules directly to the cytoplasm or nucleus, and the mechanisms underlying the most common approaches (microinjection, electroporation, and sonoporation) have been extensively investigated. In this review, we discuss established approaches, as well as emerging techniques (magnetofection, optoinjection, and combined modalities). In addition to operating principles and implementation strategies, we address applicability and limitations of various in vitro, ex vivo, and in vivo platforms. Importantly, we perform critical assessments regarding (1) treatment efficacy with diverse cell types and delivered cargo molecules, (2) suitability to different processing scales (from single cell to large populations), (3) suitability for automation/integration with existing workflows, and (4) multiplexing potential and flexibility/adaptability to enable rapid changeover between treatments of varied cell types. Existing techniques typically fall short in one or more of these criteria; however, introduction of micro-/nanotechnology concepts, as well as synergistic coupling of complementary method(s), can improve performance and applicability of a particular approach, overcoming barriers to practical implementation. For this reason, we emphasize these strategies in examining recent advances in development of delivery systems.
AB - Effective intracellular delivery is a significant impediment to research and therapeutic applications at all processing scales. Physical delivery methods have long demonstrated the ability to deliver cargo molecules directly to the cytoplasm or nucleus, and the mechanisms underlying the most common approaches (microinjection, electroporation, and sonoporation) have been extensively investigated. In this review, we discuss established approaches, as well as emerging techniques (magnetofection, optoinjection, and combined modalities). In addition to operating principles and implementation strategies, we address applicability and limitations of various in vitro, ex vivo, and in vivo platforms. Importantly, we perform critical assessments regarding (1) treatment efficacy with diverse cell types and delivered cargo molecules, (2) suitability to different processing scales (from single cell to large populations), (3) suitability for automation/integration with existing workflows, and (4) multiplexing potential and flexibility/adaptability to enable rapid changeover between treatments of varied cell types. Existing techniques typically fall short in one or more of these criteria; however, introduction of micro-/nanotechnology concepts, as well as synergistic coupling of complementary method(s), can improve performance and applicability of a particular approach, overcoming barriers to practical implementation. For this reason, we emphasize these strategies in examining recent advances in development of delivery systems.
KW - intracellular delivery
KW - lab-on-a-chip
KW - micro-/nanotechnology
KW - microfluidics
KW - transfection
UR - http://www.scopus.com/inward/record.url?scp=84887525788&partnerID=8YFLogxK
U2 - 10.1177/2211068213494388
DO - 10.1177/2211068213494388
M3 - Review article
C2 - 23813915
AN - SCOPUS:84887525788
SN - 2211-0682
VL - 19
SP - 1
EP - 18
JO - Journal of Laboratory Automation
JF - Journal of Laboratory Automation
IS - 1
ER -